Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...
An editor in his early 40s thought the tiny numb spot on his nose was innocuous. A year and six doctors later, he learned it ...
Johnson & Johnson (NYSE:JNJ), a global healthcare giant, continues to navigate a complex landscape of opportunities and ...
Under terms of the deal, AbbVie will provide Neomorph with an upfront payment and the potential to earn up to $1.64 billion ...
Co., Inc. (NYSE:MRK), a global healthcare leader, faces a complex landscape of opportunities and challenges as it navigates the competitive biopharmaceutical industry. This comprehensive analysis ...
PORT ANGELES — Dr. Allen Chen didn’t originally apply for the position of chief physician officer at Olympic Medical Center.
MidAmerica Cancer Care (MACC), a trusted name in Kansas City and western Missouri cancer care, is proud to announce it has ...
In a report released today, Roger Song from Jefferies maintained a Buy rating on Kura Oncology (KURA – Research Report), with a price target of ...
Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.
Researchers identified a 15-year shift toward surgical de-escalation in gynecologic oncology, marked by fewer surgical ...
Oncology practices at Olean General Hospital's Barry Street Health Center and at Bradford Regional Medical Center have received recertification by the Association for Clinical Oncology, an affiliate o ...
Panel participants share an optimistic outlook for integrating new innovations, tacking community-level challenges, and more.